Alzheimer’s Accountability and Investment Act

House Bill 620 - Alzheimer’s Accountability and Investment Act: Overview, Status, and Impact

Hozzl · 2024-06-25T10:49:27Z

Explore the details of House Bill 620 Alzheimer’s Accountability and Investment Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

6/25/2024, 10:49 AM

Congressional Summary of HR 620

Alzheimer's Accountability and Investment Act

This bill requires the National Institutes of Health to annually submit, beginning in FY2024, an estimate of its budget and personnel needs for carrying out initiatives pursuant to the National Alzheimer's Project directly to the President for review and transmittal to Congress. The Department of Health and Human Services and the Advisory Council on Alzheimer's Research, Care, and Services may comment on the budget estimate but may not change it.

The National Alzheimer's Project supports coordination of federal planning, research, and other efforts to address Alzheimer's disease and related dementias.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 620

Bill HR 620 is currently in the status of Bill Introduced since January 30, 2023. Bill HR 620 was introduced during Congress 118 and was introduced to the House on January 30, 2023. Bill HR 620's most recent activity was Placed on the Union Calendar, Calendar No. 442. as of May 31, 2024

Bipartisan Support of Bill HR 620

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

101

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 620

Primary Policy Focus

Health

Potential Impact Areas

- Budget process

- Government information and archives

- Neurological disorders

Alternate Title(s) of Bill HR 620

Alzheimer’s Accountability and Investment Act

To require an annual budget estimate for the initiatives of the National Institutes of Health pursuant to reports and recommendations made under the National Alzheimer's Project Act.